Role of C-Jun N-Terminal Kinases on a Stressed Epithelium: Time for Testing Isoform Specificity

Biological, physiological, and psychological stressors cause a “stress response” in our bodies. Stressors that are sensorily perceived (either acute or chronic) trigger hormonal responses from the sympathetic nervous system—the SAM and HPA axis—that effect intended organs to alert the individual. Ot...

Full description

Saved in:
Bibliographic Details
Published inBiology (Basel, Switzerland) Vol. 14; no. 6; p. 649
Main Authors Shashikanth, Nitesh, Alaidi, Osama, Basa, Lohitha, Taank, Shreya, Rao, RadhaKrishna, Seetharaman, Jayaraman
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 03.06.2025
MDPI
Subjects
Online AccessGet full text
ISSN2079-7737
2079-7737
DOI10.3390/biology14060649

Cover

More Information
Summary:Biological, physiological, and psychological stressors cause a “stress response” in our bodies. Stressors that are sensorily perceived (either acute or chronic) trigger hormonal responses from the sympathetic nervous system—the SAM and HPA axis—that effect intended organs to alert the individual. Other stressors have a direct effect on the target organ(s) of the body—e.g., physical injury and wounds, toxins, ionizing, and UV radiation. Both kinds of stressors change cell equilibrium, often leading to reactive oxygen species (ROS) accumulation and cellular damage. Among the signaling pathways involved in fighting these stressors, the c-Jun-N-terminal kinases (JNK) respond to diverse kinds of stressors. This review focuses on JNK1 and JNK2, both of which are ubiquitously present in all cell types, and attention is paid to gastrointestinal tract epithelial cells and their response—including tight junction disruption and cytoskeletal changes. We discuss the seemingly opposite roles of JNK1 and JNK2 in helping cells choose pro-survival and pro-apoptotic pathways. We examine the common features of the JNK protein structure and the possibilities of discovering JNK-isoform-specific inhibitors since, although JNK1 and JNK2 are involved in multiple diseases, including cancer, obesity, diabetes, musculoskeletal and liver disease, no cell-specific or isoform-specific inhibitors are available.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:2079-7737
2079-7737
DOI:10.3390/biology14060649